Stephanie Okey
CIK 1742616 · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.06M
Companies
4
Total Filings
36
Lifetime Open-Market Net
-$2.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTCT | Director | 8,000 | $75.14 | $601.1K | -$1.96M | 16 | 2026-03-12 |
| CRNX | Director | 13,300 | $34.47 | $458.5K | -$930.7K | 9 | 2026-03-04 |
| Catalent, Inc. (CTLT) Delisted | Director | 0 | $63.48 | $0 | $0 | 4 | 2024-12-18 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | — | $44.15 | — | $0 | 7 | 2023-03-02 |
Recent Filings · Page 4 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-16 | CRNX | Grant (A) | — | $0 | EDGAR |
| 2019-06-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-24 | PTCT | Grant (A) | — | $0 | EDGAR |
| 2018-12-18 | PTCT | Grant (A) | — | $0 | EDGAR |
| 2018-06-18 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-11 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–36 of 36
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.